Amphotericin B topical microemulsion: Formulation, characterization and evaluation

Colloids and Surfaces B: Biointerfaces

Volumn 116, Issue , 2014, Pages 351-358

  Butani, Dhruv ^a   Yewale, Chetan ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Amphotericin B; Antifungal; Microemulsion; Permeation; Topical

Indexed keywords

AMPHOTERICIN B; ANTI-FUNGAL; ANTI-FUNGAL ACTIVITY; ISOPROPYL MYRISTATE; POLYDISPERSITY INDICES; PSEUDOTERNARY PHASE DIAGRAMS; TOPICAL; ZONE OF INHIBITIONS;

FUNGI; MICROEMULSIONS; PERMEATION;

SURFACE ACTIVE AGENTS;

AMPHOTERICIN B; MYRISTIC ACID ISOPROPYL ESTER; POLYSORBATE 80; PROPYLENE GLYCOL; ANTIFUNGAL AGENT; EMULSION;

ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CONDUCTANCE; DRUG ADMINISTRATION ROUTE; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STABILITY; EX VIVO STUDY; IN VITRO STUDY; MICROEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN SENSITIVITY; TRICHOPHYTON RUBRUM; ANIMAL; CHEMISTRY; DRUG EFFECTS; EMULSION; FEMALE; MICROBIAL SENSITIVITY TEST; RABBIT; SKIN; SOLUBILITY; TOXICITY TESTING; TRICHOPHYTON; WISTAR RAT;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; EMULSIONS; FEMALE; MICROBIAL SENSITIVITY TESTS; RABBITS; RATS; RATS, WISTAR; SKIN; SKIN IRRITANCY TESTS; SOLUBILITY; TRICHOPHYTON;

EID: 84896700937     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.01.014     Document Type: Article

References (64)

1. Sperry P.J., Cua D.J., Wetzel S.A., Adler-Moore J.P. Antimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cells. Med. Mycol. 1998, 36:135-141.
2. Moreno M., Paloma F., Paloma B. Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B. Pharm. Res. 2001, 18:344-351.
3. Brajtburg J., Powderly W.G., Kobayashi G.S., Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother. 1990, 34:183-188.
4. Engelhard D., Marks M.I., Good R.A. Infections in bone marrow transplant recipients. J. Pediatr. 1986, 108:335-346.
5. Richardson S.E., Bannatyne R.M., Summerbell R.C., Milliken J., Gold R., Weitzman S.S. Disseminated fusarial infection in the immunocompromised host. Rev. Infect. Dis. 1988, 10:1171-1181.
6. Bryceson A. Therapy in man. The Leishmaniases in Biology and Medicine 1987, vol. II:847-907. Academic Press Inc. Ltd., London.
7. Mullen A.B., Carter K.C., Baillie A.J. Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis. Antimicrob. Agents Chemother. 1997, 41:2089-2092.
8. Sanchez-Brunete J.A., Dea M.A., Rama S., Bolas F., Alunda J.M., Torrado-Santiagoa S., Torradoa J.J. Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis. J. Drug Target 2004, 12:1-8.
9. Shah S.P., Misra A. Development of liposomal amphotericin B dry powder inhaler formulation. Drug Deliv. 2004, 11:247-253.
10. Amato V.S., Tuon F.F., Bacha H.A., Neto V.A., Nicodemo A.C. Mucosal leishmaniasis. Current scenario and prospects for treatment. Acta. Trop. 2008, 105:1-9.
11. Lincopan N., Borelli P., Fock R., Mamizuka E.M., Carmona-Ribeiro A.M. Toxicity of an effective amphotericin B formulation at high cationic lipid to drug molar ratio. Exp. Toxicol. Pathol. 2006, 58:175-183.
12. Naik S., Chougule M., Padhi B.K., Misra A. Development of novel lyophilized mixed micelle Amphotericin B formulation for treatment of systemic fungal infection. Curr Drug Deliv. 2005, 2:177-184.
13. Hiemenz J.W., Walsh T.J. Lipid formulations of amphotericin B: recent progress and future directions. Clin. Infect Dis. 1996, 22(Suppl. 2):S133-S144.
14. Wong-Beringer A., Jacobs R.A., Guglielmo B.J. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin. Infect Dis. 1998, 27:603-618.
15. Walters K.A. Penetration enhancers and their use in transdermal therapeutic systems. Transdermal Drug Delivery: Developmental Issues and Research Initiatives 1989, vol. 35:197-246. Marcel Dekker, New York.
16. Yamaguchi K., Mitsui T., Aso Y., Sugibayashi K. Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin. J. Pharm Sci. 2008, 97:4391-4403.
17. Vicentini F.T., Vaz M.M., Fonseca Y.M., Bentley M.V., Fonseca M.J. Characterization and stability study of a water-in-oil microemulsion incorporating quercetin. Drug Dev. Ind. Pharm. 2011, 37:47-55.
18. Yewale C., Baradia D., Vhora I., Misra A. Proteins: emerging carrier for delivery of cancer therapeutics. Expert Opin. Drug Deliv. 2013, 10:1429-1448.
19. Changez M., Chander J., Dinda A.K. Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Colloids Surf. B Biointerf. 2006, 48:58-66.
20. Chen H., Chang X., Du D., Li J., Xu H., Yang X. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int. J. Pharm. 2006, 315:52-58.
21. Gupta R.R., Jain S.K., Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf. B Biointerf. 2005, 41:25-32.
22. Peltola S., Saarinen-Savolainen P., Kiesvaara J., Suhonen T.M., Urtti A. Microemulsions for topical delivery of estradiol. Int. J. Pharm. 2003, 254:99-107.
23. Baroli B., Lopez-Quintela M.A., Delgado-Charro M.B., Fadda A.M., Blanco-Mendez J. Microemulsions for topical delivery of 8-methoxsalen. J. Control. Release 2000, 69:209-218.
24. Delgado-Charro M.B., Iglesias-Vilas G., Blanco-Méndez J., López-Quintela M.A., Marty J.-P., Guy R.H. Delivery of a hydrophilic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 1997, 43:37-42.
25. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S77-S98.
26. Campbell C.J., Rusling J.F. Electrochemical phase-transfer catalysis in microemulsions: carbene formation. Langmuir 1999, 15:7416-7417.
27. Zarur A.J., Ying J.Y. Reverse microemulsion synthesis of nanostructured complex oxides for catalytic combustion. Nature 2000, 403:65-67.
28. Al Abood R.M., Talegaonkar S., Tariq M., Ahmad F.J. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting. Colloids Surf. B Biointerf. 2013, 101:143-151.
29. Lalan M.S., Laddha N.C., Lalani J., Imran M.J., Begum R., Misra A. Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis. Drug Deliv. Transl. Res. 2012, 2:129-141.
30. Krishnaiah Y.S.R., Satyanarayana V., Karthikeyan R.S. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J. Pharm. Pharmaceut. Sci. 2002, 5:123-130.
31. Zhao X., Liu J.P., Zhang X., Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int. J. Pharm. 2006, 327:58-64.
32. Osborne D.W., Ward A.J., O'Neill K.J. Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J. Pharm. Pharmacol. 1991, 43:450-454.
33. Zhu W., Yu A., Wang W., Dong R., Wu J., Zhai G. Formulation design of microemulsion for dermal delivery of penciclovir. Int. J. Pharm. 2008, 360:184-190.
34. Hoar T., Schulman J. Transparent water-in-oil dispersions: the oleopathic hydro-micelle. Nature 1943, 152:102-103.
35. Draize J., Woodard G., Calvery H. Methods for the study of irritation and toxicity of substances topically applied to skin and mucous membranes. J. Pharmacol. Exp. Ther. 1944, 82:377-390.
36. htt p://www.fda.gov/ohrms/dockets/dailys/04/oct04/101904/04n-0050-rpt0002-tab-20-vol9.
37. Jain G.K., Sharma A., Agrawal S. Transdermal controlled administration of verapamil-enhancement of skin permeability. Int. J. Pharm. 1996, 130:169-177.
38. Dreher F., Walde P., Luisi P., Elsner P. Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. Skin Pharmacol. 1996, 9:124-129.
39. Paolino D., Ventura C.A., Nistico S., Puglisi G., Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int. J. Pharm. 2002, 244:21-31.
40. Quality control microorganism products. Microbiologics 2011, 39:25.
41. Chen H., Mou D., Du D., Chang X., Zhu D., Liu J., Xu H., Yang X. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration. Int. J. Pharm. 2007, 341:78-84.
42. Acosta E.J., Nguyen T., Witthayapanyanon A., Harwell J.H., Sabatini D.A. Linker-based bio-compatible microemulsions. Environ Sci. Technol. 2005, 39:1275-1282.
43. Gupta S., Moulik S.P. Biocompatible microemulsions and their prospective uses in drug delivery. J. Pharm. Sci. 2008, 97:22-45.
44. Panigrahi L., Ghosal S., Pattnaik S., Maharana L., Barik B. Effect of permeation enhancers on the release and permeation kinetics of lincomycin hydrochloride gel formulations through mouse skin. Indian J. Pharm. Sci. 2006, 68:205.
45. Bali V., Ali M., Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf. B: Biointerf. 2010, 76:410-420.
46. Aggarwal N., Goindi S., Mehta S.D. Preparation and evaluation of dermal delivery system of griseofulvin containing vitamin E-TPGS as penetration enhancer. AAPS PharmSciTech 2012, 13:67-74.
47. Warisnoicharoen W., Lansley A.B., Lawrence M.J. Light scattering investigations on dilute nonionic oil-in-water microemulsions. AAPS PharmSci 2000, 2:E12.
48. Philip A.K., Pathak K. Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug. Drug Dev. Ind. Pharm. 2008, 34:735-743.
49. Kreilgaard M., Pedersen E.J., Jaroszewski J.W. NMR characterisation and transdermal drug delivery potential of microemulsion systems. J. Control. Release 2000, 69:421-433.
50. Sintov A.C., Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J. Control. Release 2004, 95:173-183.
51. Kawakami K., Yoshikawa T., Hayashi T., Nishihara Y., Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study. J. Control. Release 2002, 81:75-82.
52. Hathout R.M., Elshafeey A.H. Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker. Eur. J. Pharm. Biopharm. 2012, 82:230-240.
53. Hathout R.M., Nasr M. Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies. Colloids Surf. B: Biointerf. 2013, 110:254-260.
54. Biruss B., Dietl R., Valenta C. The influence of selected steroid hormones on the physicochemical behaviour of DPPC liposomes. Chem. Phys. Lipids 2007, 148:84-90.
55. Chang X.-L., Chen H.-B., Zhao X.-Z., Gao Z.-H., Xu H.-B., Yang X.-L. High-performance liquid chromatography determination of triptolide in vitro permeation studies. Anal. Chim. Acta 2005, 534:215-221.
56. Changez M., Varshney M., Chander J., Dinda A.K. Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Colloids Surf. B: Biointerf. 2006, 50:18-25.
57. Mei Z., Chen H., Weng T., Yang Y., Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 2003, 56:189-196.
58. Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit. Rev. Ther. Drug Carrier Syst. 1999, 16:461-521.
59. Rigg P.C., Barry B.W. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J. Invest. Dermatol. 1990, 94:235-240.
60. Hathout R.M., Mansour S., Mortada N.D., Geneidi A.S., Guy R.H. Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function. Mol. Pharm. 2010, 7:1266-1273.
61. Stilbs P., Lindman B. NMR measurements on microemulsions. Surfactants, Micelles, Microemulsions and Liquid Crystals 1984, 39-47. Springer.
62. Yuan J.S., Ansari M., Samaan M., Acosta E.J. Linker-based lecithin microemulsions for transdermal delivery of lidocaine. Int. J. Pharm. 2008, 349:130-143.
63. Walters K.A., Brain K.R., Green D.M., James V.J., Watkinson A.C., Sands R.H. Comparison of the transdermal delivery of estradiol from two gel formulations. Maturitas 1998, 29:189-195.
64. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 1960, 11:85-97.